Search
211 - 220 of 485 Results
A series of stimulus-responsive protein modifications to enhance intracellular protein drug delivery.Download a .pdf version of this invention hereIntellectual PropertyUS Publication 2016
https://viceprovost.tufts.edu/chemical-modification-proteins-and-peptides-therapy
Download a .pdf version of this invention hereResearchers at Tufts University have a patent-pending compound for the delivery of cytotoxic siRNA therapeutics. This amphiphillic compound, which
https://viceprovost.tufts.edu/combinatorial-cationic-lipid-based-nanoparticles-efficient-intracellular-protein-and-nucleic-acid
Semiconductor oxides are a promising alternative to silicon-based solar cells because they possess high optical absorption and are composed of low cost materials. Cupric oxide (CuO) films have now
https://viceprovost.tufts.edu/seed-layer-assisted-chemical-bath-deposition-cuo-itoglass-substrates-tunable-crystalinity
Ionogels are hybrid materials based on ionic liquids (salts that are molten at room temperature) and a solid support material. Researchers at Tufts have now created a series of novel ionogels which
https://viceprovost.tufts.edu/pdms-supported-ionogels-and-method-produce-such-materials
Non-surgical, species agnostic animal sterilizationResearchers at Tufts University have devised a novel, fast, and non-surgical means to induce apoptosis in animal gonads. Lipid‐like carriers are used
https://viceprovost.tufts.edu/method-non-surgical-sterilization-mammals-using-antibody-guided-nanoparticle-carrying-cytotoxin
Gal-8 Inhibition as a Treatment of Diseases associated with pathological Lymphangiogenesis
Technology
Targeting Galectin-8 to prevent lymphangiogenesisLead Inventor: Dr. Noorjahan PanjwaniTufts case T001991Bussiness Opportunity: Researchers at Tufts University have shown that Galectin-8 inhibitors
https://viceprovost.tufts.edu/gal-8-inhibition-treatment-diseases-associated-pathological-lymphangiogenesis
Stabilization of therapeutic peptides by non-perturbative chemical modification US Publication No. 2019-0055279 (February 21, 2019) Licensing ContactJohn Cosmopoulosjohn.cosmopolous@tufts.edu
https://viceprovost.tufts.edu/stabilization-therapeutic-peptides-non-perturbative-chemical-modification
ELECTRONIC LARYNX
Technology
SUMMARYTufts University investigators have developed an improved artificial larynx that enables patients undergoing laryngectomies or tracheostomies to communicate with a level of expression and
https://viceprovost.tufts.edu/electronic-larynx
Tufts University investigator, Joshua Kritzer, has developed a family of modified peptides that induce the biological process of autophagy. These peptides are potential therapeutics for diseases in
https://viceprovost.tufts.edu/intrinsically-cell-penetrant-autophagy-inducing-peptides
Silk Water Lithography
Technology
SUMMARYTufts University investigators have developed a room temperature lithography technique that eliminates the need for expensive equipment and minimizes the use of harsh chemicals without
https://viceprovost.tufts.edu/silk-water-lithography